Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for Antibody Discovery at Rapid Novor.

New study shows promise for diphenyl ditelluride as anti-cancer drug

A new research paper was published in Oncotarget’s Volume 14 on June 21, 2023, entitled, “Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in

June 27, 2023

Rapport bags $150M Series B just five months after nine-figure launch for epilepsy, psychiatry trials

Just five months after emerging with $100 million to test former Janssen neuroscience programs, Rapport Therapeutics is back with another nine-figure raise to take its

August 24, 2023

FDA, Health Canada team up to raise awareness of J&J’s Megadyne recall

Dive Brief: The Food and Drug Administration and Health Canada published notices Wednesday about the potential for burn injuries in patients treated with Johnson &

August 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.